ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TYR Tyratech (DI/S)

2.95
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tyratech (DI/S) LSE:TYR London Ordinary Share COM SHS USD0.001 (DI / REGS)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.95 2.70 3.20 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

TyraTech, Inc. Envance LLC amended: Sharpened strategic focus (6242K)

20/04/2015 7:00am

UK Regulatory


Tyratech (LSE:TYR)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Tyratech Charts.

TIDMTYR TIDMTYRU

RNS Number : 6242K

TyraTech, Inc.

20 April 2015

TyraTech, Inc.

("TyraTech" or the "Company")

Envance LLC amended: TyraTech to sharpen its strategic focus

TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focused on nature-derived insect and parasite control products for the personal care and animal health markets, is pleased to announce that the Company and AMVAC, a wholly-owned subsidiary of American Vanguard Corporation (NYSE: AVD), have updated their commercial relationship and have amended the Limited Liability Company Agreement (the "Amendment") relating to Envance Technologies, LLC ("Envance"), a jointly owned enterprise. As a result, TyraTech will receive approximately $500k in cash in repayment of loans and consideration which it will re-invest into working capital and geographical expansion of its Vamousse branded products.

Envance Technologies was originally created in November 2012 to further develop and commercialise TyraTech's technology in the fields of agriculture, home, and lawn and garden. Since that time, TyraTech's primary focus, both financial and commercial, has been on its personal care (the Vamousse range of products) and animal health products. In line with this area of focus, the majority of the financing for Envance has been provided by AMVAC.

Under the terms of the Amendment, TyraTech and AMVAC agreed that Covering Capital Contributions made subsequent to the formation of Envance would be converted to Membership Interests. With this conversion, the Membership Percentage Interests in Envance would be adjusted from AMVAC owning 60 percent and TyraTech owning 40 percent to AMVAC owning 83.77 percent and TyraTech owning 16.23 percent.

Contemporaneous with the Amendment, AMVAC offered to purchase, and TyraTech agreed to sell, approximately 3 percent of its remaining ownership interest in Envance. Subsequent to this transaction, AMVAC will have a Membership Percentage Interest of 86.67 percent, and TyraTech will have a Membership Percentage Interest of 13.33 percent.

The Company considers the reduction of TyraTech's membership interest in Envance to be positive for the Company, as it allows greater focus on the Company's core markets of personal care and animal health.

The Independent Directors of TyraTech, having consulted with SPARK Advisory Partners Limited, as Nominated Adviser to the Company, consider the terms of the proposed amendment to the Envance Technologies Limited Liability Company Agreement and the sale to AMVAC to be fair and reasonable, insofar as the shareholders are concerned. In providing advice to the Independent Directors, SPARK Advisory Partners Limited has taken into account the Independent Directors' commercial assessments of this related party transaction.

Eric Wintemute, President of AMVAC, said: "By strengthening its position in Envance, AMVAC reaffirms its vision of developing innovative nature-derived products to control insects and parasites in the fields of agriculture, home, and lawn and garden. It is also a way to support more closely the development of Envance's business strategy and the continuation of its commercialisation efforts."

Bruno Jactel, Chief Executive Officer of TyraTech, said: "Over the past twelve months, having validated our entry into the personal care market with the successful launch of our Vamousse branded products in both the USA and the UK, our investment and growth pathway will be through geographic expansion of our current products, commercialisation of products in development, and continued development of our pipeline across both the personal care and animal health markets. With our sharpened strategic focus in these two markets, I am very pleased that together with TyraTech's strategic investor, AMVAC, we were able to achieve our goal of strengthening Envance as the organisation best suited to develop and commercialise TyraTech's technology for the agriculture, household, and lawn and garden markets."

 
 TyraTech Inc. 
 
  Bruno Jactel, Chief Executive Officer     Tel: +1 919 415 
  Vincent T. Morgus, Chief Financial        4340 
  Officer & Treasurer                       Tel: +1 919 415 
                                            4287 
---------------------------------------  ------------------- 
 SPARK Advisory Partners Limited, 
  Nominated Adviser                         Tel: +44203 368 
  Matt Davis / Mark Brady                   3552 
                                            Tel: +44203 368 
                                            3551 
---------------------------------------  ------------------- 
 Allenby Capital Limited , Joint Broker 
  Chris Crawford                            Tel: +44 20 3328 
                                            5656 
---------------------------------------  ------------------- 
 Whitman Howard Limited, Joint Broker 
  Ranald Mc-Gregor Smith / Niall Devins     Tel: +44 20 7087 
                                            4555 
---------------------------------------  ------------------- 
 Walbrook, Financial PR and IR 
  Guy McDougall/Nick Rome                   Tel: +44 20 7933 
                                            8780 
---------------------------------------  ------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCIRMATMBTBBPA

1 Year Tyratech Chart

1 Year Tyratech Chart

1 Month Tyratech Chart

1 Month Tyratech Chart

Your Recent History

Delayed Upgrade Clock